Comparison of two currently available anti-COVID-19 vaccines

Rafał Pawliczak

doi:10.5114/pja.2021.102554

eISSN: 2391-6052
ISSN: 2353-3854

Alergologia Polska - Polish Journal of Allergology

Current issue Archive Manuscripts accepted About the journal Supplements Special issues Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

1/2021
vol. 8

Send email

Copy url:

Review paper

Comparison of two currently available anti-COVID-19 vaccines

Rafał Pawliczak

¹

Zakład Immunopatologii, Wydział Lekarski, Oddział Nauk Biomedycznych, Uniwersytet Medyczny w Łodzi

Alergologia Polska – Polish Journal of Allergology 2021; 8, 1: 19–20

DOI: https://doi.org/10.5114/pja.2021.102554

Online publish date: 2021/01/12

Article file

- Porownanie szczepionek.pdf [0.20 MB]

Get citation

PlumX metrics:

1. Use of mRNA COVID-19 Vaccines: Interim Clinical Considerations. Advisory Committee on Immunization Practices, December 19, 2020.

2. Moderna COVID-19 Vaccine. Advisory Committee on Immunization Practices, December 19, 2020.

3. Pfizer BioNTech COVID-19 Vaccine. Advisory Committee on Immunization Practices, December 11, 2020.

4. Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med 2020; 383: 2603-2615.

5. Castells MC, Phillips EJ. Maintaining safety with SARS-CoV-2 vaccines. N Engl J Med 2020; doi: 10.1056/NEJMra2035343 [In press].

6. ChPL Comirnaty.

7. ChPL Moderna.

Copyright: © Polish Society of Allergology This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No Derivatives 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.

Comparison of two currently available anti-COVID-19 vaccines

Rafał Pawliczak 1

Rafał Pawliczak

¹